An unrestrained proinflammatory M1 macrophage population induced by iron impairs wound healing in humans and mice
Open accessThe DOI matches its Crossref record; 95 of the 95 references it cites were found in a registry or an index; 10 of the 19 sources its claims cite were checked for support.
Abstract
Uncontrolled macrophage activation is now considered to be a critical event in the pathogenesis of chronic inflammatory diseases such as atherosclerosis, multiple sclerosis, and chronic venous leg ulcers. However, it is still unclear which environmental cues induce persistent activation of macrophages in vivo and how macrophage-derived effector molecules maintain chronic inflammation and affect resident fibroblasts essential for tissue homeostasis and repair. We used a complementary approach studying human subjects with chronic venous leg ulcers, a model disease for macrophage-driven chronic inflammation, while establishing a mouse model closely reflecting its pathogenesis. Here, we have shown that iron overloading of macrophages--as was found to occur in human chronic venous leg ulcers and the mouse model--induced a macrophage population in situ with an unrestrained proinflammatory M1 activation state. Via enhanced TNF-α and hydroxyl radical release, this macrophage population perpetuated inflammation and induced a p16(INK4a)-dependent senescence program in resident fibroblasts, eventually leading to impaired wound healing. This study provides insight into the role of what we believe to be a previously undescribed iron-induced macrophage population in vivo. Targeting this population may hold promise for the development of novel therapies for chronic inflammatory diseases such as chronic venous leg ulcers.
Overview
CoChat Summary
TL;DR
In human chronic venous leg ulcers and a mouse iron-overload model, iron loading induced an unrestrained proinflammatory M1 macrophage population coexpressing CD163 that persisted and impaired wound healing. These macrophages released TNFα and hydroxyl/peroxynitrite radicals, causing fibroblast p16INK4a-dependent senescence; iron chelation, macrophage depletion, or etanercept rescued healing in mice.
Key findings
- In CVU biopsies, CD68+ macrophages represented up to 80% of cells in wound margins and persistently expressed M1 markers iNOS and TNFα in all studied CVU biopsies (patients 1–5), whereas acute wounds showed only a transient increase at day 2 and reduction by day 5. Iron deposits were found in macrophages and extracellular space in all studied CVU samples (patients 1–5 and 12–16) but were absent in acute wounds.
- In iron-dextran-treated mice, iron accumulated in F4/80+ wound macrophages; these cells showed a persistent proinflammatory M1 profile (TNFα hi, IL-12 hi, CCR2 hi, Ly6C hi) with intermediate M2 markers at day 5. Iron-loaded mice had delayed wound healing at days 3, 5, 7, and 10, and desferrioxamine prevented iron loading and rescued the healing defect.
- TNFα was causal in the mouse model: etanercept injected at day 3 rescued impaired healing at days 5, 7, and 10; clodronate liposome macrophage depletion at day 4 improved healing and fully rescued delayed repair at day 10; recombinant TNFα delayed healing in control acute wounds.
- CVUs showed prevailing O2−· and OH·, increased 8OHdG and 3-nitrotyrosine, and γH2AX and p16INK4a expression in ulcer-adjacent fibroblasts but not CD18+ leukocytes; DFX or clodronate prevented γH2AX induction in iron-loaded mice.
Methods
- Human samples: 16 patients with nonhealing CVUs (CEAP C6) persisting >4 months; 5-mm biopsies from ulcer edge and healthy skin of the same leg; acute wounds in 5 healthy volunteers biopsied at days 1, 2, and 5. Analyses included immunohistochemistry, immunofluorescence, flow cytometry, dihydrorhodamine123 ROS detection, and Western blotting.
- Mouse model: 8- to 12-week-old C57BL/6 mice received iron-dextran (5 mg i.p. every 3 days for 21 days) or PBS-dextran; selected groups received DFX (6 mg), etanercept (25 µg/wound at days 3–6), recombinant TNFα (5,000 U/wound at days 2–4), or clodronate/PBS liposomes (12.5 mg/wound at day 4). Four 6-mm full-thickness excisional wounds were made, and wound areas were quantified.
- In vitro: human PBMC-derived macrophages were treated with IFNγ/LPS, dexamethasone/IL-4, or Fenton-mimicking conditions (10 µM Fe(III) chloride, 10 µM ascorbate, 50 µM H2O2). Statistics used mean ± SD, two-tailed Student’s t test or Mann-Whitney U test, with P < 0.05 considered significant.
Limitations
- Stated: the studies do not discern whether the unrestrained proinflammatory M1 population represents a continuum of functional states within the M1/M2 framework, nor whether the phenotype arises from differentiation of initial tissue macrophages or polarization of a distinct recruited population that replaces original macrophages.
- Stated: the effect of topically applied DFX on macrophages is not known, and it remains to be seen whether beneficial outcomes from topical corticosteroids reflect a switch to antiinflammatory macrophages; T cell involvement in the pro-oxidative ulcer environment also remains unresolved.
- Evident from the text: human data are largely observational/correlative with small sample sizes (16 CVU patients; some analyses used 5 acute wounds or 5 normal-skin samples), while causal rescue evidence comes from the mouse model; no human trial targeting this macrophage population is reported.
Model-written summary. Check it against the paper before relying on it.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
6 Valid · 0 Not valid · 6 Not checked · 66 Own results and interpretations
The cited sources support only part of this claim — read each source’s verdict below.
In the paper
“there is evidence from 2 independent reports that intracellular iron activates NFκ B, the major transcription factor of genes including, among others, proinflammatory TNFα in a model of LPS-stimulated (59) or iron-loaded rat liver macrophages (60).”
What the sources say
- Supportedcites [59] Xiong, 2003, J Biol Chem. source
The Abstract reports that a rise in intracellular iron preceded NF-κB activation in LPS-stimulated hepatic macrophages, and that iron chelators blocked both responses. It also states that direct addition of ferrous iron to cultured hepatic macrophages activated NF-κB (page not specified in our copy). (LLM, conf=0.93)
- Partly supportedcites [60] matched to “Iron Causes Interactions of TAK1, p21ras, and Phosphatidylinositol 3-Kinase in Caveolae to Activate IκB Kinase in Hepatic Macrophages” (2007) sourceExperimental — accuracy not yet measured
The Results report that ferrous sulfate activates IκB kinase (IKK) in cultured rat hepatic macrophages and increases TNFα release. The paper links intracellular iron signaling to NFκB activation in its introductory discussion, but the reported iron-treatment experiment measures IKK activity, not NFκB activation itself. The claim therefore goes beyond what this paper directly shows for iron-loaded rat liver macrophages. (LLM, conf=0.84)
hedgedstates a cause- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: passes — The paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
- Supported
The cited sources support only part of this claim — read each source’s verdict below.
In the paper
“we showed here that accelerated aging of ulcer resident fibroblasts was rather caused by the installment of a p16 INK4a -dependent senescence program in vivo.”
What the sources say
- Partly supportedcites [62] matched to “Fibroblast Dysfunction Is a Key Factor in the Non-Healing of Chronic Venous Leg Ulcers” (2008) sourceExperimental — accuracy not yet measured
The Abstract reports that chronic wound fibroblasts had a shorter proliferative lifespan and earlier senescence than patient-matched normal fibroblasts. The Discussion (section labelled “IB Wall et al.”) suggests oxidative stress could explain this early senescence, but our copy does not establish a p16INK4a-dependent mechanism or show that it caused aging in vivo. (LLM, conf=0.88)
boostedstates a cause- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: passes — The paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
- Rests on an assumption not shown here.
- Partly supported
The cited sources support only part of this claim — read each source’s verdict below.
In the paper
“topical application of infliximab, a chimeric IgG1 monoclonal antibody that binds with high affinity and specificity to the soluble and transmembrane TNFα , resulted in significant improvement of healing in 12 of 14 previously therapy-resistant CVUs (12).”
What the sources say
- Partly supportedcites [12] matched to “Topical application of the tumour necrosis factor‐α antibody infliximab improves healing of chronic wounds” (2006) sourceExperimental — accuracy not yet measured
The Results report healing or substantial size reduction in many of the 14 therapy-resistant ulcers after topical infliximab, supporting the reported improvement. But Materials and methods identifies the 14 wounds as a mixed group, including traumatic leg ulcers and scrotal ulcers—not 14 chronic venous ulcers (CVUs). The study also describes a case series rather than a statistically significant treatment effect. (LLM, conf=0.90)
plainstates a cause- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: passes — The paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
- Partly supported
Every source the paper cites for this claim was checked and supports it.
In the paper
“Our in vivo data corroborated and extended previous in vitro data that ulcer-derived fibroblast cultures undergo accelerated replicative senescence (62).”
What the sources say
- Supportedcites [62] matched to “Fibroblast Dysfunction Is a Key Factor in the Non-Healing of Chronic Venous Leg Ulcers” (2008) source
The section “CWF have a decreased replicative life span compared with NF” reports that cultured fibroblasts from chronic venous leg ulcers became senescent after fewer population doublings than patient-matched normal fibroblasts. It also reports greater senescence-associated β-galactosidase activity in the ulcer-derived cultures at late passage. (LLM, conf=0.93)
plainstates an association- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: unclear — It is unclear whether the paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
- Supported
The cited sources support only part of this claim — read each source’s verdict below.
In the paper
“The identification of iron accumulation in macrophages as the prime event in the complex pathogenesis of CVUs eventually driving persistent inflammation and tissue damage is also of major relevance for other chronic inflammatory disorders with enhanced iron storage in macrophages, like arteriosclerosis, multiple sclerosis, and other neurodegenerative diseases (79-82).”
What the sources say
- Partly supportedcites [79] matched to “The Big Idea: Iron-Dependent Inflammation in Venous Disease and Proposed Parallels in Multiple Sclerosis” (2006) sourceExperimental — accuracy not yet measured
Split into 2 atoms — 0 confirmed, 2 partially supported, 0 disputed, 0 misattributed, 0 unverifiable. Expand the claim to see per-atom verdicts.
- Partly supportedcites [80] matched to “Direct Detection and Quantification of Transition Metal Ions in Human Atherosclerotic Plaques: Evidence for the Presence of Elevated Levels of Iron and Copper” (2004) sourceExperimental — accuracy not yet measured
Split into 2 atoms — 0 confirmed, 2 partially supported, 0 disputed, 0 misattributed, 0 unverifiable. Expand the claim to see per-atom verdicts.
- Could not verifycites [81] matched to “Fibroblasts cultured from venous ulcers display cellular characteristics of senescence” (1998) sourceExperimental — accuracy not yet measured
Split into 2 atoms — 0 confirmed, 0 partially supported, 0 disputed, 0 misattributed, 2 unverifiable. Expand the claim to see per-atom verdicts.
- Partly supportedcites [82] matched to “The iron hypothesis of atherosclerosis and its clinical impact” (2003) sourceExperimental — accuracy not yet measured
Split into 2 atoms — 1 confirmed, 1 partially supported, 0 disputed, 0 misattributed, 0 unverifiable. Expand the claim to see per-atom verdicts.
plainstates a cause- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: unclear — It is unclear whether the paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
- Partly supported
43 more claims
Create a free account to see all 78 claims and every source verdict.
- Probably not a substantial claim. 7
- It may state two separate claims as one. 26
- The quote only partly states this claim. 1
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“Indeed, in mouse and human skin wounds and in injured mouse kidney, Mp expression of CD206 increases during the later stages of repair [33,60,61,63].”
From Macrophage phenotypes during tissue repair (2013) · cites this paper as [61]
Experimental — accuracy not yet measuredThe source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“The M1-associated cytokines IL-1, TNF-␣, IL-6, and IL-12 are expressed by Mp during the first few hours to days after acute injury in numerous tissues, including skin [33,60,61], liver [62], kidney [63], and skeletal muscle [57,64].”
From Macrophage phenotypes during tissue repair (2013) · cites this paper as [61]
Experimental — accuracy not yet measuredThe source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“Recent studies by Sindrilaru et al. (2011) and Sindrilaru (2013) have identified a subset of iron-overloaded inflammatory M1-like macrophages, which are implicated in the pathogenesis of CVD.”
From The role of iron in the skin and cutaneous wound healing (2014) · cites this paper as Sindrilaru et al. (2011)
Experimental — accuracy not yet measuredThe source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“Moreover, the reactive oxygen species (ROS) production by macrophages is also regulated by the balance of CB1 and CB2 activation, which is an important factor contributing to the persistent inflammation in chronic wounds and increasing the senescence of dermal fibroblasts [63, 110].”
From Transition from inflammation to proliferation: a critical step during wound healing (2016) · cites this paper as [63]
Experimental — accuracy not yet measuredThe cited source says what the claim attributes to it.
In the citing paper
“For example, iron overload drives macrophages into an unrestrained pro-inflammatory M1-activation state, and iron-overloaded macrophages have been detected in human chronic venous ulcers [63, 64].”
From Transition from inflammation to proliferation: a critical step during wound healing (2016) · cites this paper as [63]
10 more claims about this paper
Create a free account to see every claim other papers make about this one.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
Each contradiction between two passages listed here was confirmed by an independent check.
Rated minor: it would not touch a result — a value no result rests on, a p-value that stays on the same side of the significance level, or a conflict that is clerical, resolved elsewhere in the paper, or outside its own findings.
In the paper
§ Results · p. 2
“intermediate expression levels of M2 markers (arginase, CD206, Dectin-1, IL-10, IL-4R α , and CD36) was observed in all macrophages in the studied tissue samples from CVU patients”
§ Discussion · p. 7
“M2 cytokines like IL-10 - which are virtually absent in the proinflammatory M1 macrophages in nonhealing CVUs”
Citations
Cites
Exploring the full spectrum of macrophage activation
Mosser, D. M., & Edwards, J. P. (2008) · Nature Reviews Immunology · doi:10.1038/nri2448 · Cited by 9,144
Martin, R. (1986) · Medical Entomology and Zoology · Cited by 8,752
The chemokine system in diverse forms of macrophage activation and polarization
MANTOVANI, A., SICA, A., SOZZANI, S., ALLAVENA, P., VECCHI, A., & LOCATI, M. (2004) · Trends in Immunology · doi:10.1016/j.it.2004.09.015 · Cited by 6,534
Alternative activation of macrophages
Gordon, S. (2003) · Nature Reviews Immunology · doi:10.1038/nri978 · Cited by 6,189
Singer, A. J., & Clark, R. A. F. (1999) · New England Journal of Medicine · doi:10.1056/nejm199909023411006 · Cited by 6,106
Monocyte and macrophage heterogeneity
Gordon, S., & Taylor, P. R. (2005) · Nature Reviews Immunology · doi:10.1038/nri1733 · Cited by 5,190
Wound Healing--Aiming for Perfect Skin Regeneration
Martin, P. (1997) · Science · doi:10.1126/science.276.5309.75 · Cited by 4,804
Maintenance infliximab for Crohn's disease: the ACCENT I randomised trial
Hanauer, S. B., Feagan, B. G., Lichtenstein, G. R., Mayer, L. F., Schreiber, S., Colombel, J. F., Rachmilewitz, D., Wolf, D. C., Olson, A., Bao, W., et al. (2002) · The Lancet · doi:10.1016/s0140-6736(02)08512-4 · Cited by 4,169
Infliximab and Methotrexate in the Treatment of Rheumatoid Arthritis
Lipsky, P. E., van der Heijde, D. M. F. M., St. Clair, E. W., Furst, D. E., Breedveld, F. C., Kalden, J. R., Smolen, J. S., Weisman, M., Emery, P., Feldmann, M., et al. (2000) · New England Journal of Medicine · doi:10.1056/nejm200011303432202 · Cited by 2,996
A DNA damage checkpoint response in telomere-initiated senescence
Fagagna, F. D. D., Reaper, P. M., Clay-Farrace, L., Fiegler, H., Carr, P., von Zglinicki, T., Saretzki, G., Carter, N. P., & Jackson, S. P. (2003) · Nature · doi:10.1038/nature02118 · Cited by 2,917
Research works printed but not linked: 2
- Dow, 1999, Ostomy Wound Manage., 45, 23
- Leibovich, 1975, Am J Pathol., 78, 71
Cited by
Items 601–700 of 1,097
Naoxintong accelerates diabetic wound healing by attenuating inflammatory response
Fang, L., Chen, L., Song, M., He, J., Zhang, L.-S., Li, C.-X., Wang, Q., Yang, W., Sun, W., Leng, Y., et al. (2021) · Pharmaceutical Biology · doi:10.1080/13880209.2021.1877735 · Cited by 25
“Therefore, M2 macrophages secrete high amounts of IL-10 and TGF-b to suppress the inflammation, contribute to tissue repair, remodelling, vasculogenesis and retain homeostasis (Sindrilaru et al. 2011; Gallagher et al. 2015).”
BackgroundA double-edged sword with a therapeutic target: iron and ferroptosis in immune regulation
Ni, S., Yuan, Y., Song, S., & Li, X. (2022) · Nutrition Reviews · doi:10.1093/nutrit/nuac071 · Cited by 30
Morita, T., Nakano, D., Kitada, K., Morimoto, S., Ichihara, A., Hitomi, H., Kobori, H., Shiojima, I., & Nishiyama, A. (2015) · European Journal of Pharmacology · doi:10.1016/j.ejphar.2015.03.053 · Cited by 26
“…of macrophage infiltration is that the inhibition of dietary iron absorption itself and/or the possible reduction of intra-macrophage iron suppressed macrophage sensitivity to inflammatory stimuli (Alcantara and Boldt, 2007; Persson et al., 2013; Sindrilaru et al., 2011; Valenti et al., 2011).”
BackgroundPraziquantel Targets M1 Macrophages and Ameliorates Splenomegaly in Chronic Schistosomiasis
Kong, D., Zhou, C., Guo, H., Wang, W. T., Qiu, J., Liu, X., Liu, J., Wang, L., & Wang, Y. (2017) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.00005-17 · Cited by 27
“For example, the unrestrained activation of proinflammatory M1 macrophages is considered to be a critical event in the pathogenesis of chronic venous leg ulcers (49).”
BackgroundMukai, K., Komatsu, E., Nakajima, Y., Urai, T., Nasruddin, N., Sugama, J., & Nakatani, T. (2014) · PLoS ONE · doi:10.1371/journal.pone.0115564 · Cited by 32
“However, the following results from this research might show that estrogen administration minimizes the influence of protein malnutrition to induce normal wound healing: the number of neutrophils in the PM OVX+17b-estradiol group was significantly decreased from days 3 to 7 the same as that in the Control SHAM group;…”
MethodAligned Ice Templated Biomaterial Strategies for the Musculoskeletal System
Diaz, F., Forsyth, N. R., & Boccaccini, A. R. (2023) · Advanced Healthcare Materials · doi:10.1002/adhm.202203205 · Cited by 24
Oxygen‐Releasing Hydrogels for Tissue Regeneration
Jiang, S., Zheng, Y., Xia, H., Liu, Z., Rao, S., Wang, Y., Sun, H., Lu, X., & Xie, C. (2024) · Advanced NanoBiomed Research · doi:10.1002/anbr.202300133 · Cited by 27
SENP3 sensitizes macrophages to ferroptosis via de-SUMOylation of FSP1
Chen, X., Wang, J., Yang, P., Liu, H.-Y., Zhong, S., Lu, C., Gao, M., Liu, D., Zhang, J., Wang, J., et al. (2024) · Redox Biology · doi:10.1016/j.redox.2024.103267 · Cited by 30
“Iron overload [53] and increased ROS [54] have been identified as causes of unrestrained proinflammatory M1 macrophage population infiltration in chronic non-healing wounds.”
BackgroundValsami, E., Chu, G., Guan, M., Gilman, J., Theocharidis, G., & Veves, A. (2025) · Advances in Therapy · doi:10.1007/s12325-025-03212-9 · Cited by 27
Torregrossa, M., Kakpenova, A., Simon, J. C., & Franz, S. (2021) · Biological Chemistry · doi:10.1515/hsz-2021-0145 · Cited by 27
Modulation of the Immune System Promotes Tissue Regeneration
Masoomikarimi, M., & Salehi, M. (2022) · Molecular Biotechnology · doi:10.1007/s12033-021-00430-8 · Cited by 31
“In this case, macrophages also reduce the levels of anti-inflammatory markers such as IL-10 and IL-4 [24].”
BackgroundInfluentialLiang, C., Xiong, N., Liu, M., Chen, Y., Li, W., Xu, J., Sun, Y., Wang, Y., Dong, Y., Fan, W., et al. (2022) · Nano Today · doi:10.1016/j.nantod.2022.101670 · Cited by 23
Jauch, A. S., Wohlfeil, S. A., Weller, C., Dietsch, B., Häfele, V., Stojanovic, A., Kittel, M., Nolte, H., Cerwenka, A., Neumaier, M., et al. (2022) · Cancer Cell International · doi:10.1186/s12935-022-02800-x · Cited by 26
Liu, T., Zhang, Q., Liu, L., Xu, X., Chen, H., Wang, H., Kong, L., Wang, W., Zhang, A., Cai, Y., et al. (2013) · Parasitology Research · doi:10.1007/s00436-013-3475-3 · Cited by 25
Murine macrophages response to iron
Polati, R., Castagna, A., Bossi, A., Alberio, T., Domenico, I. D., Kaplan, J., Timperio, A. M., Zolla, L., Gevi, F., D’Alessandro, A., et al. (2012) · Journal of Proteomics · doi:10.1016/j.jprot.2012.07.018 · Cited by 25
IκB Kinase Activity Drives Fetal Lung Macrophage Maturation along a Non-M1/M2 Paradigm
Stouch, A. N., Zaynagetdinov, R., Barham, W. J., Stinnett, A., Slaughter, J. C., Yull, F. E., Hoffman, H. M., Blackwell, T. S., & Prince, L. S. (2014) · The Journal of Immunology · doi:10.4049/jimmunol.1302516 · Cited by 22
Distinct Profiles of CD163-Positive Macrophages in Idiopathic Interstitial Pneumonias
Yamashita, M., Saito, R., Yasuhira, S., Fukuda, Y., Sasamo, H., Sugai, T., Yamauchi, K., & Maemondo, M. (2018) · Journal of Immunology Research · doi:10.1155/2018/1436236 · Cited by 25
Maguire, G. (2019) · PubMed Central · Cited by 31
Optical functional nanomaterials for cancer photoimmunotherapy
Liu, L., Pan, Y., Ye, L., Liang, C., Mou, X., Dong, X., & Cai, Y. (2024) · Coordination Chemistry Reviews · doi:10.1016/j.ccr.2024.216006 · Cited by 23
Immunity‐Modulating Metal‐Based Nanomaterials for Cancer Immunotherapy
Sun, X., Xu, X., Li, F., Wang, H., Sun, Y., Yang, H., Li, X., Kong, B., Hou, H., Liu, H., et al. (2025) · Advanced Functional Materials · doi:10.1002/adfm.202502646 · Cited by 31
Safety Issues in Iron Treatment in CKD
Vaziri, N. D. (2016) · Seminars in Nephrology · doi:10.1016/j.semnephrol.2016.02.005 · Cited by 25
Mahon, O. R., Browe, D. C., Díaz‐Payno, P. J., Pitacco, P., Cunningham, K. T., Mills, K. H. G., Dunne, A., & Kelly, D. J. (2021) · Journal of Immunology and Regenerative Medicine · doi:10.1016/j.regen.2021.100041 · Cited by 24
Zhao, Y., Zhao, Y., Tian, Y., & Zhou, Y. (2022) · Experimental and Therapeutic Medicine · doi:10.3892/etm.2022.11573 · Cited by 23
Nature-Inspired Bioactive Compounds: A Promising Approach for Ferroptosis-Linked Human Diseases?
Hajj, S. E., Canabady‐Rochelle, L., & Gaucher, C. (2023) · Molecules · doi:10.3390/molecules28062636 · Cited by 25
“Furthermore, ferroptosis inhibitors, such as Fer-1, DFO, and vitamin E, can prevent atherosclerosis [129,130].”
BackgroundLuo, L., Ma, X., Kong, D., Dai, Y., Li, T., Yu, H., Liu, J., Li, M., Xu, Y., Guo, X., et al. (2024) · Journal of Neuroinflammation · doi:10.1186/s12974-024-03226-0 · Cited by 24
“Con-currently, immune cells in IA are strongly associated with OS; for example, neutrophils release peroxidase, while M1 macrophages secrete high concentrations of superoxide and reactive nitrogen to increase OS in tissues [7, 9].”
BackgroundDüvel, A., Frank, C., Schnapper, A., Schuberth, H., & Sipka, A. S. (2012) · Innate Immunity · doi:10.1177/1753425912446954 · Cited by 23
“A recently published study, however, linked the iron uptake of macrophages promoted by CD163 to a pro-inflammatory macrophage phenotype.(25) The intracellular expression of the calcium binding protein Calprotectin can be induced in human monocytes by IL-1b, TNF-a and LPS, and is related to monocytes and freshly recrui…”
BackgroundNishiwaki, S., Nakayama, T., Murata, M., Nishida, T., Sugimoto, K., Saito, S., Kato, T., Mizuno, H., Imahashi, N., Seto, A., et al. (2012) · International Journal of Hematology · doi:10.1007/s12185-012-1023-z · Cited by 22
“Uncontrolled macrophage activation can be harmful [2] even though macrophages play an indispensable role in both innate and acquired immunity.”
BackgroundIxmyelocel-T, an expanded multicellular therapy, contains a unique population of M2-like macrophages
Ledford, K. J., Zeigler, F., & Bartel, R. L. (2013) · Stem Cell Research & Therapy · doi:10.1186/scrt345 · Cited by 23
“This study further examined the expanded population of macrophages found in ixmyelocel-T, since macrophages have been reported to play specific and unique roles in tissue regeneration and repair [7,17,46].”
BackgroundMon, H. H., Christo, S. N., Ndi, C. P., Jasieniak, M., Rickard, H., Hayball, J. D., Griesser, H. J., & Semple, S. J. (2015) · Journal of Natural Products · doi:10.1021/acs.jnatprod.5b00833 · Cited by 25
Guillén‐Gómez, E., daSilva, I., Silva, I., Arce, Y., Facundo, C., Ars, E., Breda, A., Ortíz, A., Guirado, L., Ballarín, J., et al. (2016) · American Journal of Transplantation · doi:10.1111/ajt.13998 · Cited by 23
“M1 macrophages, via TNF-a, can perpetuate inflammation, leading to impaired wound healing (46).”
BackgroundBiomimetic Chiral Nanotopography for Manipulating Immunological Response
He, Y., Zhang, X., Meng, F., Wang, J., Li, Y., Zhang, Y., Song, W., Li, T., & Zhang, Y. (2023) · Advanced Functional Materials · doi:10.1002/adfm.202313157 · Cited by 27
Ferroptosis is an effective strategy for cancer therapy
Khan, A., Huo, Y., Guo, Y., Shi, J., & Hou, Y. (2024) · Medical Oncology · doi:10.1007/s12032-024-02317-5 · Cited by 25
“M2 macrophages may evolve into M1 macrophages when exposed to radiated tumour cell-released microparticles (RT-MPs) [157].”
Targeting and activation of macrophages in leishmaniasis. A focus on iron oxide nanoparticles
Palomino-Cano, C., Moreno, E., Irache, J. M., & Espuelas, S. (2024) · Frontiers in Immunology · doi:10.3389/fimmu.2024.1437430 · Cited by 33
Targeting ferroptosis promotes diabetic wound healing via Nrf2 activation
Wang, T., Yin, Z., Zhang, J., & Wu, Z. (2024) · Heliyon · doi:10.1016/j.heliyon.2024.e37477 · Cited by 39
“In a previous mouse model of overload of iron, the iron chelator, deferasirox, was shown to enhance wound healing[28].”
Yu, S., Wu, T., Xu, K., Liu, R.-Y., Yu, T., Wang, Z., & Zhang, Z. (2025) · Materials Today Bio · doi:10.1016/j.mtbio.2025.101740 · Cited by 28
“M1 macrophages are crucial for pathogen clearance and the removal of necrotic tissue, in addition to their role in degrading and phagocytizing biological materials [61,62].”
The Role of Iron in the Susceptibility of Neonatal Mice to Escherichia coli K1 Sepsis
Michels, K. R., Lambrecht, N., Carson, W. F., Schaller, M. A., Lukacs, N. W., & Bermick, J. (2019) · The Journal of Infectious Diseases · doi:10.1093/infdis/jiz282 · Cited by 20
de Andrade, R. C. L. C., de Araújo, N. K., Torres-Rêgo, M., Furtado, A. A., Daniele-Silva, A., Paiva, W. D. S., Dantas, J. M. D. M., da Silva, N. S., da Silva-Júnior, A. A., Ururahy, M. A. G., et al. (2021) · International Journal of Molecular Sciences · doi:10.3390/ijms221910631 · Cited by 20
Han, C., Yang, Y., Sheng, Y., Wang, J., Zhou, X., Li, W., Guo, L., Zhang, C., & Ye, Q. (2021) · Aging · doi:10.18632/aging.203567 · Cited by 21
“(1) Detection of the proportion of F4/80CD86M1 cells by flow cytometry [11]: After LPS/IFN-γ treatment to induce M1 polarization for 48 h, SMG cells were centrifuged, washed with pre-cooled PBS twice, fixed with pre-cooled methanol, incubated with FITC-labeled CD86 monoclonal antibody and PE-labeled F4/80 monoclonal a…”
MethodShiji, R., Joseph, M. M., Sen, A., Pillai, R. K., Unnikrishnan, B. S., & Sreelekha, T. T. (2022) · International Journal of Biological Macromolecules · doi:10.1016/j.ijbiomac.2022.07.185 · Cited by 22
Calreticulin: a multifunctional protein with potential therapeutic applications for chronic wounds
Sawaya, A. P., Vecin, N. M., Burgess, J. L., Ojeh, N. O., DiBartolomeo, G., Stone, R. C., Pastar, I., & Tomic‐Canic, M. (2023) · Frontiers in Medicine · doi:10.3389/fmed.2023.1207538 · Cited by 23
“Monocytes immediately follow and appear at the site of injury where they are activated in response to microbial products and inflammatory mediators that enable the transition to M1 macrophages, a pro-inflammatory phenotype that aids in preventing infection (49, 50).”
BackgroundPratsinis, H., Armatas, A. A., Dimozi, A., Lefaki, M., Vassiliu, P., & Kletsas, D. (2013) · Wound Repair and Regeneration · doi:10.1111/wrr.12110 · Cited by 21
Ferric pyrophosphate citrate: interactions with transferrin
Pratt, R. D., Handelman, G. J., Edwards, T. E., & Gupta, A. (2018) · BioMetals · doi:10.1007/s10534-018-0142-2 · Cited by 20
Miura, T., Kawakami, K., Kanno, E., Tanno, H., Tada, H., Sato, N., Airi, M., Yokoyama, R., Kawamura, K., Kitai, Y., et al. (2018) · Journal of Investigative Dermatology · doi:10.1016/j.jid.2018.10.015 · Cited by 25
Functional Regulation of Macrophage Phenotypes by MicroRNAs in Inflammatory Arthritis
Niu, X., & Schulert, G. S. (2019) · Frontiers in Immunology · doi:10.3389/fimmu.2019.02217 · Cited by 24
“These generally limit immune response by secreting suppressive cytokines, reducing pro-inflammatory factors, and increasing expression of scavenger receptors which participates in fibrosis (6, 7).”
BackgroundMirastschijski, U., Schwab, I., Coger, V., Zier, U., Rianna, C., He, W., Maedler, K., Kelm, S., Radtke, A., Belge, G., et al. (2020) · Scientific Reports · doi:10.1038/s41598-020-59394-5 · Cited by 56
The lactylation-macrophage interplay: implications for gastrointestinal disease therapeutics
Che, X., Zhang, Y., Chen, X., Xie, G., Li, J., Xu, C., Zhang, C., Zhu, Y., & Yang, X. (2025) · Frontiers in Immunology · doi:10.3389/fimmu.2025.1608115 · Cited by 34
Perng, V., Navazesh, S. E., Park, J., Arballo, J., & Ji, P. (2022) · Nutrients · doi:10.3390/nu14153100 · Cited by 20
“Iron overloading of macrophages observed in human chronic venous leg ulcers and a mouse model resulted in more profound M1 polarization and lasting inflammation in vivo [15].”
BackgroundYi, J., Deng, Q., Liu, Z., Wang, H., Liu, X., Ren, J., & Qu, X. (2023) · Small · doi:10.1002/smll.202301096 · Cited by 21
Nain, A., Tseng, Y., Gupta, A., Lin, Y., Sangili, A., Huang, Y., Huang, C., & Chang, H. (2023) · Nanoscale Horizons · doi:10.1039/d3nh00275f · Cited by 24
Myeloid Cell–Restricted STAT3 Signaling Controls a Cell-Autonomous Antifibrotic Repair Program
Do, N., Willenborg, S., Eckes, B., Jüngst, C., Sengle, G., Zaucke, F., & Eming, S. A. (2018) · The Journal of Immunology · doi:10.4049/jimmunol.1701791 · Cited by 23
“Impaired wound healing is often underlaid with a persistent and chronic local inflammatory response leading to tissue fibrosis (2, 6, 7, 37).”
BackgroundLei, Z., Cao, Z., Yang, Z., Ao, M., Jin, W., & Yu, L. (2018) · Planta Medica · doi:10.1055/a-0725-8456 · Cited by 26
Zhao, Q. S., Wang, X., Hu, Q., Zhang, R., & Yin, Y. (2018) · Journal of Pharmacy and Pharmacology · doi:10.1111/jphp.13048 · Cited by 22
“When stimulated, macrophages switching from one functional subset to another plays a major role in various chronic inflammatory diseases.([10]) The pro-inflammatory and antimicrobial M1 macrophages secreted pro-inflammatory mediators such as nitric oxide (NO), interleukin-1 (IL-1) and tumour necrosis factor (TNF), con…”
BackgroundDhall, S., Hoffman, T., Sathyamoorthy, M., Lerch, A., Jacob, V., Moorman, M., Kuang, J.-Q., & Danilkovitch, A. (2019) · Advances in Wound Care · doi:10.1089/wound.2018.0931 · Cited by 21
“The chronic wound milieu as published in numerous reports is linked to proinflammatory M1 macrophage polarization.(12,34,35) It is tempting to speculate that the downregulation of IL1b and TNF-a and the upregulation of IL-4 and IL-10 by VLAM in db/db mouse wounds leads to a shift in macrophage polarization.”
BackgroundThe developing immune network in human prenatal skin
Botting, R. A., & Haniffa, M. A. (2020) · Immunology · doi:10.1111/imm.13192 · Cited by 19
Therapeutic strategies of iron-based nanomaterials for cancer therapy
Wu, X., & Zhang, H. (2020) · Biomedical Materials · doi:10.1088/1748-605x/abd0c4 · Cited by 20
“Iron-based nanomaterials can change the tumor microenvironment from immunosuppression to immunostimulat-ory through regulation of TAM phenotypes (M1 and M2) [9, 25–27].”
Myeloid Cells in Cutaneous Wound Repair
Cash, J. L., & Martin, P. B. (2016) · Microbiology Spectrum · doi:10.1128/microbiolspec.mchd-0017-2015 · Cited by 24
The emerging role and therapeutical implications of ferroptosis in wound healing
Zhao, Y., Chen, Z., Xie, S., Xiao, F., Hu, Q., & Ju, Z. (2025) · Burns & Trauma · doi:10.1093/burnst/tkae082 · Cited by 25
“Additionally, iron accumulation in macrophages can drive polarization by increasing ROS production and inducing p53 acetylation [66–68].”
dECM restores macrophage immune homeostasis and alleviates iron overload to promote DTPI healing
Ju, Z., Si, R., Gao, Y., Shan, H., Su, Q., Feng, Z., Huang, P., Kong, D., & Wang, W. (2024) · Regenerative Biomaterials · doi:10.1093/rb/rbad118 · Cited by 19
Snyder, R., Schultz, G., Wachuku, C. D., Rashid, A. M., & Ead, J. K. (2020) · Journal of the American Podiatric Medical Association · doi:10.7547/20-140 · Cited by 35
Engineering Immunomodulatory Biomaterials to Drive Skin Wounds toward Regenerative HealingPreprint
Butenko, S., Miwa, H., Liu, Y., Plikus, M. V., Scumpia, P. O., & Liu, W. F. (2022) · Cold Spring Harbor Perspectives in Biology · doi:10.1101/cshperspect.a041242 · Cited by 25
Linares-Alcántara, E., & Mendlovic, F. (2022) · Immunological Investigations · doi:10.1080/08820139.2021.2020812 · Cited by 21
“The recognition of SR-A1 by the 2F8 mAb in B6 mice has been independently reported by others (Sindrilaru et al. 2011; Yi et al. 2012).”
BackgroundWang, X., Cheng, Y., Han, X., Yan, J., Wu, Y., Song, P., Wang, Y., Li, X., & Zhang, H. (2022) · Advanced Healthcare Materials · doi:10.1002/adhm.202200776 · Cited by 18
Cai, X., Ruan, L., Wang, D., Zhang, J., Tang, J., Guo, C., Dou, R., Zhou, M., Hu, Y., & Chen, J. (2023) · Colloids and Surfaces B Biointerfaces · doi:10.1016/j.colsurfb.2023.113664 · Cited by 19
Zou, Y.-P., Shan, X., Qiu, J., Wang, L., Xiang, R., & Cai, Z. (2024) · Biomedicine & Pharmacotherapy · doi:10.1016/j.biopha.2024.116468 · Cited by 26
Tissue‐resident macrophages — how to humanize our knowledge
Schlitzer, A., & Schultze, J. L. (2016) · Immunology and Cell Biology · doi:10.1038/icb.2016.82 · Cited by 23
Yuan, H., He, J., Zhang, G., Zhang, D., Kong, X., & Chen, F. (2017) · Acta Biochimica et Biophysica Sinica · doi:10.1093/abbs/gmx092 · Cited by 18
Magnetic Nanoparticles for Cancer Therapy and Bioimaging
Polo, E., del Pino, P., Pardo, A., Taboada, P., & Pelaz, B. (2018) · Nanomedicine and nanotoxicology · doi:10.1007/978-3-319-89878-0_7 · Cited by 22
Spontaneous Development of Autoimmune Uveitis Is CCR2 Dependent
Chen, Y. F., Zhou, D., Metzger, T. C., Gallup, M., Jeanne, M., Gould, D. B., Anderson, M. S., & McNamara, N. A. (2014) · American Journal Of Pathology · doi:10.1016/j.ajpath.2014.02.024 · Cited by 20
Dou, R., Wang, L., Zhang, J., Cai, X., Tang, J., Liu, X., Hu, Y., & Chen, J. (2025) · Small · doi:10.1002/smll.202409052 · Cited by 18
Bai, X., Li, Y., Wang, P., Xu, Z., Wei, J., He, T., & Han, J. (2025) · Burns & Trauma · doi:10.1093/burnst/tkaf017 · Cited by 24
“In both diabetic patients and mice, approximately 80% of the cells at the edges of chronic wounds are proinflammatory M1 macrophages, which do not transition promptly to the anti-inflammatory M2 phenotype [9].”
RETRACTED: Anti-microbial/oxidative/inflammatory nanogels accelerate chronic wound healing
Nain, A., Tseng, Y., Gupta, A., Lin, Y., Sangili, A., Huang, Y., Huang, C., & Chang, H. (2021) · Smart Materials in Medicine · doi:10.1016/j.smaim.2021.12.006 · Cited by 17
RetractedNiebergall‐Roth, E., Frank, N. Y., Ganss, C., Frank, M. H., & Kluth, M. A. (2022) · International Journal of Molecular Sciences · doi:10.3390/ijms24010066 · Cited by 22
“In an iron-overload mouse wound model mimicking the chronic inflammatory state of nonhealing human venous ulcers, which is characterized by persistent, unrestrained M1 macrophage activation [94], ABCB5+ MSCs injected intradermally around the wound edges of full-thickness excisional wounds localized within the wound be…”
BackgroundInfluentialWoo, S., Mo, Y. J., Lee, Y., Park, J. H., Hwang, D., Park, T. J., Kang, H. Y., Park, S. C., & Lee, Y. (2023) · Journal of Investigative Dermatology · doi:10.1016/j.jid.2023.05.002 · Cited by 21
Wang, Y., Qiu, H., Chen, S., Li, D., Zhao, X., Guo, M., Li, N., Chen, C., Qin, M., Zhou, Y., et al. (2024) · Aging Cell · doi:10.1111/acel.14145 · Cited by 17
CHOP ‐mediated hepcidin suppression modulates hepatic iron load
Mueller, K., Sunami, Y., Stützle, M., Güldiken, N., Kücükoglu, Ö., Mueller, S., Kulaksiz, H., Schwarz, P., & Strnad, P. (2013) · The Journal of Pathology · doi:10.1002/path.4221 · Cited by 19
“These data are in line with previous observations of macrophage iron accumulation in chronic tissue injury [28,29].”
ResultTuning the Intrinsic Nanotoxicity in Advanced Therapeutics
Wang, S., Li, F., Hu, X., Lv, M., Fan, C., & Ling, D. (2018) · Advanced Therapeutics · doi:10.1002/adtp.201800059 · Cited by 20
Nrf2-Mediated Expansion of Pilosebaceous Cells Accelerates Cutaneous Wound Healing
Muzumdar, S., Hiebert, H., Haertel, E., Greenwald, M. B., Bloch, W., Werner, S., & Schäfer, M. (2018) · American Journal Of Pathology · doi:10.1016/j.ajpath.2018.11.017 · Cited by 17
Ziemba, A. M., D’Amato, A. R., MacEwen, T. M., Puhl, D. L., Koppes, A. N., Koppes, R. A., Lennartz, M. R., & Gilbert, R. J. (2019) · ACS Applied Bio Materials · doi:10.1021/acsabm.8b00769 · Cited by 20
Targeting Iron Dyshomeostasis for Treatment of Neurodegenerative Disorders
Bergsland, N., Tavazzi, E., Schweser, F., Jakimovski, D., Hagemeier, J., Dwyer, M. G., & Zivadinov, R. (2019) · CNS Drugs · doi:10.1007/s40263-019-00668-6 · Cited by 20
Zhang, W., Li, L., Wu, Y., Li, C., Xu, Z., Zhang, N., Wang, X., Zhao, Y., Zu, T., He, Q., et al. (2024) · International Journal of Nanomedicine · doi:10.2147/ijn.s473463 · Cited by 19
“53,54 Iron-based nanoparticles have emerged as pivotal translational entities in confronting TAMs that foster immune responses and sensitize tumors to immunotherapies safely and effectively, such as MNPs@MDSCs, 55 Fe@PDA-PEG, 56 and PLGA-ION-R837@M.”
BackgroundSilva, J. D., Figueiredo, A., Tseng, Y., Carvalho, E., & Leal, E. C. (2025) · International Journal of Molecular Sciences · doi:10.3390/ijms26052036 · Cited by 19
“The presence of inflammatory cells leads to a persistent release of pro-inflammatory cytokines such as TNF-α and IL-6, among others [10,41].”
In Vitro Model of Macrophage-Biomaterial Interactions
Witherel, C. E., Graney, P. L., & Spiller, K. L. (2018) · Methods in molecular biology · doi:10.1007/978-1-4939-7741-3_13 · Cited by 19
Sharawy, N., Imam, A. A.-A., Aboulhoda, B. E., Khalifa, M. M., Morcos, G. N. B., Algaleel, W. A. A., Moustafa, P. E., Elbaset, M. A., & Shoukry, T. M. (2022) · Frontiers in Physiology · doi:10.3389/fphys.2022.953206 · Cited by 16
“In atherosclerotic plaque, iron overload was found to polarize macrophages toward the M1 phenotype, thus leading to progression of the disease (Sindrilaru et al., 2011; Kamanna et al., 2012).”
BackgroundThe relation between BTK expression and iron accumulation of myeloid cells in multiple sclerosis
Steinmaurer, A., Riedl, C. J., König, T., Testa, G., Köck, U., Bauer, J., Lassmann, H., Höftberger, R., Berger, T., Wimmer, I., et al. (2024) · Brain Pathology · doi:10.1111/bpa.13240 · Cited by 18
Doyle, K. P., Quach, L. N., Arceuil, H. E. D., & Buckwalter, M. S. (2014) · Neuroscience Letters · doi:10.1016/j.neulet.2014.10.041 · Cited by 17
“demonstrated that iron uptake by mononuclear phagocytes can cause cells to adopt a proinflammatory M1 phenotype [20], and because mononuclear cells migrate to the stroke, the administration of ferumoxytol could make the inflammatory response to stroke more damaging.”
BackgroundIn vivo response to decellularized mesothelium scaffolds
Cronce, M. J., Faulknor, R. A., Pomerantseva, I., Liu, X., Goldman, S. M., Ekwueme, E. C., Mwizerwa, O., Neville, C. M., & Sundback, C. A. (2018) · Journal of Biomedical Materials Research Part B: Applied Biomaterials · doi:10.1002/jbm.b.33879 · Cited by 16
Pericytes in Cutaneous Wound Healing
Morikawa, S., Iribar, H., Gutiérrez‐Rivera, A., Ezaki, T., & Izeta, A. (2019) · Advances in experimental medicine and biology · doi:10.1007/978-3-030-16908-4_1 · Cited by 18
Sayama, K., Yuki, K., Sugata, K., Fukagawa, S., Yamamoto, T., Ikeda, S., & Murase, T. (2021) · Scientific Reports · doi:10.1038/s41598-020-79519-0 · Cited by 18
Qi, M., Zhu, X., Yu, X., Ai, M., Cai, W., Du, B., Hou, B., & Qiu, L. (2021) · Nanomaterials · doi:10.3390/nano11112830 · Cited by 18
“Substantial evidence suggests that in chronic ulcers, the infiltration of pro-inflammatory cells mainly composed of neutrophils and macrophages increases, leading to delayed wound healing [42,43].”
BackgroundPan, T., Chang, Y., He, M. Y., He, Z., Jiang, J., Ren, X., & Zhang, F. (2022) · Pharmaceutical Biology · doi:10.1080/13880209.2022.2046111 · Cited by 17
“Generally, inflammation can protect the body from injury or infection by endogenous and exogenous pathogens; it can also lead to serious tissue damage once excessive and unresolved inflammatory responses (Grivennikov et al. 2010; Sindrilaru et al. 2011).”
BackgroundEfficacy of Aeschynomene indica L. leaves for wound healing and isolation of active constituent
Lei, Z.-Y., Chen, J., Cao, Z., Ao, M., & Yu, L. (2018) · Journal of Ethnopharmacology · doi:10.1016/j.jep.2018.08.008 · Cited by 20
Macrophages: diversity of phenotypes and functions, interaction with foreign materials
Sarbaeva, N. N., Ponomareva, J. V., & Milyakova, M. N. (2016) · Genes and Cells · doi:10.23868/gc120550 · Cited by 31
Marine bioactive peptides as potential therapeutic agents for wound healing – a review
Zheng, K., Yang, Z., & Ba, T. (2025) · Annals of Medicine · doi:10.1080/07853890.2025.2530693 · Cited by 23
“Chronic wounds exhibit a significant rise in neutrophils [37], pro-inflammatory macrophages [38], Langerhans cells [39], IL-1β and proteases [40,41], linked to clinical ulcer severity [42].”
Nishiwaki, S., Saito, S., Takeshita, K., et al. (2020) · PLoS ONE · doi:10.1371/journal.pone.0242488 · Cited by 15
Aljamal, D., Iyengar, P. S., & Nguyen, T. (2024) · Pharmaceutics · doi:10.3390/pharmaceutics16060750 · Cited by 18
“Animal models for venous ulcers commonly use mice overloaded with iron-dextran via intraperitoneal or subcutaneous injection until there are skin hemosiderin deposits [167].”
BackgroundCabrales, P., Scicinski, J. J., Reid, T. R., Kuypers, F. A., Larkin, S. K., Fens, M. H. A. M., Oronsky, A. L., & Oronsky, B. T. (2016) · Medical Oncology · doi:10.1007/s12032-016-0775-3 · Cited by 15
Black, White, and Gray: Macrophages in Skin Repair and Disease
Rodrigues, M., & Gurtner, G. C. (2017) · Current Pathobiology Reports · doi:10.1007/s40139-017-0152-8 · Cited by 17
Durose, W. W., Shimizu, T., Li, J., Abe, M., Sakimura, K., Chetsawang, B., Tanaka, K. F., Suzumura, A., Tohyama, K., & Ikenaka, K. (2018) · Journal of Neurochemistry · doi:10.1111/jnc.14581 · Cited by 19
“The pro-inflammatory damaging (M1) macrophages, induced by TNFa, were present in the chronic demyelinated region and correlated with CatC expression (Sindrilaru et al. 2011).”
BackgroundSree, V. D., Rausch, M. K., & Tepole, A. B. (2019) · Mechanics Research Communications · doi:10.1016/j.mechrescom.2019.05.003 · Cited by 15
Bayer, M. L., de Bang, L., Kalisz, M. H., Svensson, R. B., Olesen, J. L., Karlsson, M. M., Schjerling, P., Hellsten, Y., Høier, B., Magnusson, S. P., et al. (2019) · The FASEB Journal · doi:10.1096/fj.201900542r · Cited by 14
Metadata
- Authors
- Sindrilaru, A., Peters, T., Wieschalka, S., Baican, C., Baican, A., Peter, H., Hainzl, A., Schatz, S., Qi, Y., Schlecht, A., Weiss, J. M., Wlaschek, M., Sunderkötter, C., & Scharffetter-Kochanek, K.
- Affiliations
- Universität Ulm (DE)
- University of Münster (DE)
- ORCID
- Venue
- Journal of Clinical Investigation
- Published
- 2011-03-01
- Volume
- 121
- Issue
- 3
- Pages
- 985-997
- ISSN
- 0021-9738 (ISSN-L)
- PMC
- PMC3049372
- OpenAlex
- W2019583561
- Cited by
- 1,100
- References
- 92
- Citations by year
- 2026: 50 · 2025: 61 · 2024: 95 · 2023: 80 · 2022: 77 · 2021: 87 · 2020: 76 · 2019: 87 · 2018: 85 · 2017: 90 · 2016: 75 · 2015: 60 · 2014: 64 · 2013: 49 · 2012: 39
- FWCI
- 56.78
- Type
- journal article
- Language
- en
- Open access
- bronze
- doi.org
- Locations
- Journal of Clinical Investigation (publishedVersion)
- PubMed Central (publishedVersion)
- PubMed (publishedVersion)
- Funders
- Baden-Württemberg Stiftung
- European Commission (223236)
- Deutsche Forschungsgemeinschaft (SU 195/3-1, KFO 142, SFB 497)
- Universität Ulm
- Topics
- Health Sciences › Medicine › Surgery › Wound Healing and Treatments
- Life Sciences › Immunology and Microbiology › Immunology › Immune cells in cancer
- Health Sciences › Medicine › Surgery › Diagnosis and Treatment of Venous Diseases
- Keywords
- M1 macrophages, chronic venous leg ulcers, wound healing, chronic inflammation, fibroblast senescence, p16INK4a, TNF-α, hydroxyl radicals, macrophage activation, tissue repair
- MeSH terms
- Animals, Fibroblasts, Humans, Inflammation, Iron, Macrophages, Models, Biological, Phenotype, Tumor Necrosis Factor-alpha, Wound Healing, Cellular Senescence, Reactive Oxygen Species, Hydroxyl Radical, Cyclin-Dependent Kinase Inhibitor p16, Mice
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
The claim verdicts this report counts are experimental: their accuracy is not yet measured.
A language model drew the claims from the paper on 2026-10-10, under version 3 of the claim definition (model deepseek-v4.1-flash, prompt extract-v3).
A second model labelled each claim on 2026-10-10 (model jev-1.13-20260917, definition revision gold-guideline-v0.2).
Cited sources are checked with a language model’s help (gpt-6-sol).
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.





